Furthermore, we investigated the mechanism of AR inhibition and the antiandrogenic effects of these PFASs on the expression of androgen responsive genes and intracellular AR protein levels in androgen sensitive human prostate cancer cells. Here, AR is linked to prostate carcinoma.